Not Tagged
merck,ngm biopharmaceuticals,sanofi
['$ngm', '$mrk', 'merck', '$sny']
$agen $jnce $ngm $mrk $sny asco 2022 merck s follow-on immuno-oncology plan hits a myositis problem 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities